The Impact of the Myeloid Response to Radiation Therapy
Radiation therapy is showing potential as a partner for immunotherapies in preclinical cancer models and early clinical studies. As has been discussed elsewhere, radiation provides debulking, antigen and adjuvant release, and inflammatory targeting of effector cells to the treatment site, thereby as...
Saved in:
Main Authors: | Michael J. Gough, Kristina Young, Marka Crittenden |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/281958 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma
by: Andrea Emanuele Guerini, MD, et al.
Published: (2025-03-01) -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Rachel Bergerson, et al.
Published: (2011-01-01) -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
by: Angela Stoddart, et al.
Published: (2011-05-01) -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
by: Xenofon Papanikolaou, et al.
Published: (2011-10-01) -
Urothelial Superior Vena Cava Syndrome with Limited Response to Radiation Therapy
by: Nishan Bingham, et al.
Published: (2015-01-01)